Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Integrin function in breast carcinoma progression.

L M Shaw1

  • 1Dana 601, Beth Israel, Deaconess Medical Center, Boston, Massachusetts 00215, USA. shaw@caregroup.harvard.edu

Journal of Mammary Gland Biology and Neoplasia
|March 8, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: How Will Aducanumab Approval Impact AD Research?

The journal of prevention of Alzheimer's disease·2021
Same author

Postoperative pulmonary complications following major head and neck cancer surgery.

International journal of oral and maxillofacial surgery·2020
Same author

Beclin 1 regulates growth factor receptor signaling in breast cancer.

Oncogene·2015
Same author

FASTKD2 is associated with memory and hippocampal structure in older adults.

Molecular psychiatry·2014
Same author

Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals.

Translational psychiatry·2014
Same author

CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders.

Translational psychiatry·2013
Same journal

In Vitro Model of Milking Pulses and Stretching Cycles: Assessing Mechanical Effects on Bovine Mammary Cells.

Journal of mammary gland biology and neoplasia·2026
Same journal

Looking in the Rear-View Mirror: How Lineage Tracing Experiments Redefined Cell Hierarchy in the Mammary Gland.

Journal of mammary gland biology and neoplasia·2026
Same journal

Expression of Estrogen Receptor Alpha and Ki-67 in Synchronous Canine Mammary Tumors.

Journal of mammary gland biology and neoplasia·2026
Same journal

A-to-I RNA Editing Endows miR-3664-5p with Carcinogenicity in Breast Cancer Through Modulating LONP2 Mediated Glycolysis.

Journal of mammary gland biology and neoplasia·2026
Same journal

Exploring the Molecular and Genomic Landscape of the Dark Agouti Rat Mammary Adenocarcinoma: Preliminary Insights for Triple-Negative Breast Cancer Modeling.

Journal of mammary gland biology and neoplasia·2026
Same journal

Psychological Stress Increases the Expression of Milk-Derived miR-210-5p.

Journal of mammary gland biology and neoplasia·2026
See all related articles

Integrin receptors play a crucial role in breast cancer progression. Targeting specific integrin receptors (alpha2beta1, alpha6beta1, alpha6beta4) offers potential therapeutic strategies for breast cancer intervention.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Mammary epithelial cell function relies on growth factor/hormone and integrin receptors.
  • Integrin receptors are increasingly recognized for their role in carcinoma cell behavior and breast cancer progression.
  • Altered integrin expression and function during cellular transformation significantly impact breast carcinoma development.

Purpose of the Study:

  • To review integrin-dependent functions in breast cancer.
  • To identify integrin receptors as potential therapeutic targets for breast cancer intervention.
  • To discuss emerging signaling targets within integrin-dependent pathways.

Main Methods:

  • Correlative studies to link integrin expression with breast carcinoma progression.

Related Experiment Videos

  • Mechanistic studies to elucidate the role of integrins in breast cancer.
  • Literature review focusing on integrin-dependent signaling pathways.

    • Main Results:

    • Specific integrin receptors, including alpha2beta1, alpha6beta1, and alpha6beta4, are implicated in breast carcinoma progression.
    • Integrin-dependent functions can be manipulated for therapeutic purposes.
    • Potential integrin-dependent signaling targets have been identified.

    Conclusions:

    • Integrin receptors are critical mediators of breast carcinoma progression.
    • Targeting specific integrins presents a promising avenue for breast cancer therapy.
    • Further research into integrin signaling pathways is warranted for developing novel treatments.